Your browser doesn't support javascript.
loading
Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features.
Gangaev, Anastasia; Ketelaars, Steven L C; Isaeva, Olga I; Patiwael, Sanne; Dopler, Anna; Hoefakker, Kelly; De Biasi, Sara; Gibellini, Lara; Mussini, Cristina; Guaraldi, Giovanni; Girardis, Massimo; Ormeno, Cami M P Talavera; Hekking, Paul J M; Lardy, Neubury M; Toebes, Mireille; Balderas, Robert; Schumacher, Ton N; Ovaa, Huib; Cossarizza, Andrea; Kvistborg, Pia.
Afiliação
  • Gangaev A; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • Ketelaars SLC; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • Isaeva OI; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • Patiwael S; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • Dopler A; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • Hoefakker K; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • De Biasi S; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.
  • Gibellini L; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.
  • Mussini C; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.
  • Guaraldi G; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.
  • Girardis M; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.
  • Ormeno CMPT; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands.
  • Hekking PJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands.
  • Lardy NM; Department of Immunogenetics, Sanquin Diagnostics B.V., Amsterdam, North Holland, The Netherlands.
  • Toebes M; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • Balderas R; Department of Biological Sciences, BD Biosciences, San Jose, CA, USA.
  • Schumacher TN; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.
  • Ovaa H; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands.
  • Cossarizza A; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.
  • Kvistborg P; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands. p.kvistborg@nki.nl.
Nat Commun ; 12(1): 2593, 2021 05 10.
Article em En | MEDLINE | ID: mdl-33972535
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epitopos Imunodominantes / Linfócitos T CD8-Positivos / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epitopos Imunodominantes / Linfócitos T CD8-Positivos / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article